Clinical Trials List
2020-03-01 - 2027-12-30
Phase III
Recruiting6
ICD-10C64.1
Malignant neoplasm of right kidney, except renal pelvis
ICD-10C64.2
Malignant neoplasm of left kidney, except renal pelvis
ICD-10C64.9
Malignant neoplasm of unspecified kidney, except renal pelvis
ICD-10C7A.093
Malignant carcinoid tumor of the kidney
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9189.0
Malignant neoplasm of kidney, except pelvis
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Yen-Hwa Chang 無
- 沈書慧 無
- 陳威任 無
- Tzu-Ping Lin 未分科
- Tzu-Hao Huang 無
- Tzu-chun Wei 無
- Yi-Hsiu Huang 無
- 潘競成 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yuh-Shyan Tsai 無
- Wu-Chou Su 無
- Jui-Hung Tsai 無
- 楊舜如 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shau-Hsuan Li 無
- 吳佳哲 無
- 劉建廷 無
- Tai-Jan Chiu 無
- 賴香蘭 無
- 陳彥仰 無
- 陳彥豪 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chuan-Shu Chen 無
- 洪晟鈞 無
- 王樹吉 無
- 裘坤元 無
- 盧嘉文 Division of Urology
- 林雁婷 無
- Cheng-Kuang Yang 無
- 梅承恩 無
- Cheng-Che Chen 無
- 張瓈文 無
- Shian-Shiang Wang 無
- Chia-Yen Lin 無
- 熊小澐 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
約12 participants
-
Global
約736 participants
